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Chronic Pseudomonas aeruginosa lung infection is the most severe complication in
patients with cystic fibrosis (CF). The infection is characterized by the formation of biofilm
surrounded by numerous polymorphonuclear leukocytes (PMNs) and strong O2 depletion
in the endobronchial mucus. We have reported that O2 is mainly consumed by the
activated PMNs, while O2 consumption by aerobic respiration is diminutive and nitrous
oxide (N2O) is produced in infected CF sputum. This suggests that the reported growth
rates of P. aeruginosa in lungs and sputum may result from anaerobic respiration using
denitrification. The growth rate of P. aeruginosa achieved by denitrification at physiological
levels (∼400µM) of nitrate (NO−3 ) is however, not known. Therefore, we have measured
growth rates of anoxic cultures of PAO1 and clinical isolates (n = 12) in LB media
supplemented with NO−3 and found a significant increase of growth when supplementing
PAO1 and clinical isolates with ≥150µMNO− and 100µ3 M NO−3 , respectively. An essential
contribution to growth by denitrification was demonstrated by the inability to establish a
significantly increased growth rate by a denitrification deficient nirS-N mutant at <1mM
of NO−3 . Activation of denitrification could be achieved by supplementation with as little
as 62.5µM of NO−3 according to the significant production of N2O by the nitrous oxide
reductase deficient nosZ mutant. Studies of the promoter activity, gene transcripts,
and enzyme activity of the four N-oxide reductases in PAO1 (Nar, Nir, Nor, Nos) further
verified the engagement of denitrification, showing a transient increase in activation and
expression and rapid consumption of NO−3 followed by a transient increase of NO
−
2 .
Growth rates obtained by denitrification in this study were comparable to our reported
growth rates in the majority of P. aeruginosa cells in CF lungs and sputum. Thus, we
have demonstrated that denitrification is required for P. aeruginosa growth in infected
endobronchial CF mucus.
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INTRODUCTION
Chronic lung infection by Pseudomonas aeruginosa is the most
severe complication in cystic fibrosis (CF) patients (Koch and
Høiby, 2000). The infection is characterized by biofilm aggregates
of P. aeruginosa within the endobronchial mucus surrounded by
high densities of active polymorphonuclear leukocytes (PMNs)
(Bjarnsholt et al., 2009). The activity of PMNs has been shown
to be the major cause of O2 depletion due to production of the
reactive oxygen species superoxide (O−2 ) and nitric oxide (NO)
within sputum samples (Kolpen et al., 2010, 2014a). Combined
with the O2 consumption by lung epithelial cells, micro-oxic
to anoxic conditions can develop in the airways of CF patients
(Worlitzsch et al., 2002), which have been further evidenced by
the upregulation of the O2 sensing anaerobic global regulator
(Anr) in P. aeruginosa isolates (Hoboth et al., 2009) and the
presence of obligate anaerobes such as Prevotella within sputum
(Tunney et al., 2008). While O2 depletion by microbial aerobic
respiration is thus diminutive, P. aeruginosa has been shown to be
actively growing within the mucus of lungs (Kragh et al., 2014)
and sputum (Yang et al., 2008). As a facultative anaerobe, this
growth may be attributable to P. aeruginosa’s ability to perform
anaerobic respiration by denitrification.
Denitrification was first described as the liberation of gaseous
nitrogen oxides (N-oxides) by bacteria (Gayon and Dupetit,
1886) and involves the utilization of N-oxides as alternative
electron acceptors for respiration (Figure 1). This definition of
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denitrification means that while nitrate (NO−3 ) reduction to
nitrite (NO−2 ) contributes directly to energy generation via the
proton pumping action of the membrane-bound nitrate reduc-
tase (NarGHIJ) (Chen and Strous, 2013), the first step in strict
denitrification is actually NO−2 reduction, where NO is the first
gaseous product arising from NO−3 reduction (Zumft, 2005).
Engagement of denitrification in infected CF lungs is in
accordance with the production of the denitrification interme-
diate nitrous oxide (N2O) in sputum (Kolpen et al., 2014b),
FIGURE 1 | Denitrification pathway. Reduction of nitrate to nitrite, nitric
oxide, nitrous oxide, and finally dinitrogen. The four reductase enzymes
nitrate reductase, nitrite reductase, nitric oxide reductase, and nitrous oxide
reduction are boxed below. Nitrite reduction marks the first step of strict
denitrification.
the presence of the denitrification marker OprF and antibod-
ies against OprF in lung secretions and sera (Yoon et al., 2002),
antibodies against Nar in sera (Beckmann et al., 2005) and the
upregulation of the denitrification reductases in CF isolates (Son
et al., 2007; Hoboth et al., 2009; Lee et al., 2011). Additionally,
after antimicrobial treatment the infected sputum content of
NO−3 increases (Grasemann et al., 1998) indicating a reduction
in the activity of denitrifying cells.
MATERIALS AND METHODS
BACTERIAL STRAINS AND PLASMIDS
The strains and plasmids used in this study are listed in Table 1.
Primers used in this study are listed in Table 2. The wild
type strain used for experiments and reporter plasmid inser-
tion was PAO1 obtained from the Pseudomonas Genetic Stock
Center (www.pseudomonas.med.ecu.edu, strain PAO0001). The
Holloway PAO1 wild type was used as the control for the exami-
nations of the Holloway PAO1 nirS-N and the Holloway PAO1
nosZ mutants. The PAO1 strains grew at similar rates under
anoxic conditions.
Table 1 | P. aeruginosa strains used for this study.
Strains and plasmids Details Study
PLASMIDS
pMEXGFP pMEX9 derived promoter-probe vector; egfp Gmr Toyofuku et al., 2013
pMEXdsREDex pMEX9 derived promoter-probe vector; dsredexpress Gmr This study
pMNarK1-GFP narK1 promoter region fused to egfp in pMEXGFP This study
pMNirS-dsREDex nirS promoter region fused to dsredexpress in pMEXdsREDex This study
pMNorC-GFP norC promoter region fused to egfp in PMEXGFP This study
pMNosR-dsREDex nosR promter region fused to dsredexpress in pMEXdsREDex This study
pET15b Expression vector Apr Novagen, Madison, WI, USA
pG19nir nirS to nirN deletion cassette in PG19II Toyofuku et al., 2013
pG19nos nosZ deletion cassette in PG19II This study
STRAINS
E. coli
S17-1 Mobilizer strain Simon et al., 1986
P. aeruginosa
PAO1 MH340 WT Pseudomonas Genetic Stock Center
PAO1 egfp Background control Toyofuku et al., 2013
PAO1 dsredexpress Background control This study
PAO1 narK1-eGFP Nitrate reductase reporter This study
PAO1 nirS-dsredexpress Nitrite reductase reporter This study
PAO1 norC-eGFP Nitric oxide reductase reporter This study
PAO1 nosR-dsredexpress Nitrous oxide reductase reporter This study
Holloway PAO1 WT Holloway et al., 1979
Holloway nirS-N nirS to nirN deleted mutant Toyofuku et al., 2013
Holloway nosZ nosZ deleted mutant This study
I M/NM Clinical isolate Kolpen et al., 2014c
II M/NM Clinical isolate Kolpen et al., 2014c
III M/NM Clinical isolate Kolpen et al., 2014c
IV M/NM Clinical isolate Kolpen et al., 2014c
V M/NM Clinical isolate Kolpen et al., 2014c
VI NM Clinical isolate Kolpen et al., 2014c
VII NM Clinical isolate Kolpen et al., 2014c
Gmr (Gentamicin resistant), Apr (Ampicillin resistant), Mucoid (M), Non-mucoid (NM), Wild type (WT).
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Table 2 | Primer sequences used in this study.
Primers Sequence Study
REPORTER PLASMIDS
Gfp F1 5′ – ACGCCAAGCTTGCATGCCTG – 3′ Toyofuku et al., 2013
pET15b-kpn 5′ – GGGGTACCACTTTAAGAAGGAGATATACCATGG – 3′ Toyofuku et al., 2013
dsred R1 5′ – GGGCTCGAGCTACAGGAACAGGTGGTGGCGGC – 3′ This study
dsred R2 5′ – CGAGCTCCTACAGGAACAGGTGGTGGCGGC – 3′ This study
pNarK1 F 5′ – GGAATTCCCGGCGTGGTTGATCACCGC – 3′ This study
pNarK1 R 5′ – TTCAAGCTTAGGCCAGGCCGTAGATCGGG – 3′ This study
pNirS F 5′ – CCCAAGCTTCTTTCATGTCGTCCTTGGCGTG – 3′ This study
pNirS R 5′ – CCCAAGCTTGCCCTTGAGCAATACCGGCAG – 3′ This study
pNorC F 5′ – CGGAATTCGCGAGCGCTTCATGGAGCTGG – 3′ This study
pNorC R 5′ – GCCAAGCTTGCCGAAATAGATGTTCCTGGCC – 3′ This study
pNosR F 5′ – CGGGATCCCCTGGTACCGTTACCTGAAGGC – 3′ This study
pNosR R 5′ – CCCAAGCTTGGATCACCTGCAGGTTGATCGG – 3′ This study
MUTANTS
nirS-N F1 5′ – CGGAATTCCCAGTAGAGGGTGAAGAAAGTGTCGTGC – 3′ Toyofuku et al., 2013
nirS-N R1 5′ – CGGGATCCGACCGGAATCAAGATTGCGTTGCTTTGC – 3′ Toyofuku et al., 2013
nirS-N F2 5′ – CGGGATCCGGTCGAGACGCCATCAACGGATATCC – 3′ Toyofuku et al., 2013
nirS-N R2 5′ – CCGAAGCTTGCGATGTTCACCATGATGAACTACGAGC – 3′ Toyofuku et al., 2013
nosZ F1 5′ – CGCAAGCTTGGGTCTGGTACCAGAAGAGTTTCCAGG – 3′ This study
nosZ R1 5′ – GACTAGTGTCGCTCATCTCGTGTCGTCCTCAAGGG – 3′ This study
nosZ F2 5′ – GACTAGTCCGCAACAGACCTCGTCGATCACC – 3′ This study
nosZ R2 5′ – CGCAAGCTTCGAGTAGGTGATGTAGTTCATCAGGATGCC – 3′ This study
qPCR
narK1F 5′ – CTCCTCCTGCTTCATGTTGCT – 3′ This study
narK1R 5′ – TGCTGCTTGATCGCGTAGTG – 3′ This study
nirS F 5′ – GGCGGCTCGCTGTTCAT – 3′ This study
nirS R 5′ – TGAAGGTGGTGTCGACGTAGAG – 3′ This study
norC F 5′ – AAGGCATGGCCAGGAACAT – 3′ This study
norC R 5′ – CCAGGAACAGCAGGATGAAGA – 3′ This study
nosZ F 5′ – CGCTGCACACCACTTTCG – 3′ This study
nosZ R 5′ – CACCAACTGGCTGTCGATGA – 3′ This study
rpoD F 5′ – ACAAGATCCGCAAGGTACTGAAG –3′ This study
rpoD R 5′ – CGCCCAGGTGCGAATC – 3′ This study
Forward (F), Reverse (R).
Plasmids containing eGFP or DsRed-Express tagged reporter
genes were derived from pME as pG19nir and pG19nos plasmids
carrying deletion cassettes of nirS to nirN and nosZ were con-
structed with the same procedure described previously (Maseda
et al., 2004). The pG19II-derived plasmids were transferred into
Holloway PAO1 by conjugating with E. coli S17-1 (Simon et al.,
1986) followed by homologous recombination described else-
where (Maseda et al., 2004). The mutants were analyzed by
polymerase chain reaction (PCR) (Toyofuku et al., 2013).
The eGFP-based promoter probe plasmid, pMEXGFP, was
constructed as described previously (Toyofuku et al., 2013). The
promoter regions of narK1 and norC were amplified with pNarK1
F/pNarK1 R or pNorC F/pNorC R primer pairs and cloned into
pMEXeGFP for promoter activity assays. pMEXdsREDex was
constructed in the same way, with dsredexpress amplified using
the primer pairs Gfp F1/dsred R1 (Table 2) and post subcloning,
the primer pair pET15b-kpn/dsred R2 (Table 2) was used to
amplify a RBS-fused DsRed-Express to clone into the pMEX9
plasmid (Toyofuku et al., 2007). The promoter regions of nirS and
nosR were amplified with the primer pairs pNirS F/pNirS R or
pNosR F/pNosR R (Table 2) and cloned into the pMEdsREDex
for promoter activity assays.
The reporter plasmid insertion was achieved by preparation
of electro-competent cells as previously described (Choi et al.,
2005) and subsequent electroporation at 25µF, 200, 2.5 kV
with 1µl of plasmid DNA for 100µl of electro-competent cells.
Transformed cells were selected for by plating with 30 ng ml−1
gentamicin (Sigma-Aldrich, St. Louis, MO, USA) and frozen
cultures were produced from a single colony.
Clinical strains (5 mucoid and 7 non-mucoid) were isolated
from expectorated sputum of 7 chronically infected CF patients
(Kolpen et al., 2014b).
ANOXIC GROWTH EXPERIMENTS
In this study, we first establish experimental evidence for the abil-
ity of physiological levels of NO−3 to support anoxic growth of
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P. aeruginosa PAO1 wild type and 12 clinical isolates at rates
comparable to those in CF lungs and sputum. To discern that a
significant portion of the attained growth was attributable to den-
itrification, a strain incapable of denitrification due to a mutation
in the nitrite reductase (Nir) operon was studied.
All experiments requiring anoxic conditions were performed
in an anoxic bench (Concept 400, Thermo Scientific, Waltham,
MA, USA) with O2 <0.02% routinely monitored with an lumi-
nescent dissolved oxygen O2 sensor (HQ40d multi, HACH
Company, Loveland, CO, US). Media was sealed with parafilm
(Bemis, Neenah, WI, USA) and allowed to equilibrate for a min-
imum of 3 days. Strains were plated from frozen cultures and
single colonies were used to initiate normoxic overnight cul-
tures. They were then adjusted to OD600 0.1 and regrown to
OD600 0.4 to ensure all cells were in the exponential growth
phase. The culture was inoculated by diluting 1:100 in rele-
vant anoxic Luria-Bertani broth (LB) media supplemented with
KNO3 (Sigma-Aldrich) to obtain the noted concentrations of
NO−3 in 2ml glass vials (Schuett Biotec, Göttingen, DE), which
were sealed inside the anoxic bench before transfer to shaking
at 200 rpm. Physiological levels of NO−3 here are considered to
be approximately 400µM with a maximum of 1mM based on
the concentrations of NO−3 detected in CF sputum (Grasemann
et al., 1998; Palmer et al., 2007; Kolpen et al., 2014a). Vials were
shown to remain anoxic for a minimum of 2 days using anaer-
obic indicator strips (SSI Diagnostica, Hillerød, Denmark) that
changed from white to blue in the presence of oxygen. Optical
density was measured directly in the vials at 600 nm (OD600) by
a spectrophotometer (Shimadzu, Kyoto, JP) and values obtained
were shown to correlate linearly to dilutions of an overnight cul-
ture in LB at OD600 values > 0.02. Accordingly, only OD values
higher than 0.02 were used in growth rate calculations. Growth
rates were calculated as described (Widdel, 2007).
The suitability of the assay was demonstrated in cultures of
PAO1 supplemented with 100mM NO−3 , where our measured
growth rate of 0.7 divisions h−1 and final OD600 of 1.0 (data not
shown) corresponded well with previously reported growth rates
of P. aeruginosa (Alvarez-Ortega and Harwood, 2007; Lee et al.,
2012; Fang et al., 2013).
PROMOTER ACTIVITY—REPORTER STRAINS
To further confirm the engagement of denitrification, the tran-
scripts and promoter activity of the four N-oxide reductases
(Nar, Nir, Nor, Nos) were studied using qRT-PCR and fluo-
rescent reporter strains, respectively. Reporter strains with the
promoter region of the four denitrification reductase oper-
ons; narK1K2GHIJ, nirSMCFDLGHJEN, norCBD, nosRZDFYL
(Schobert and Jahn, 2010) fused to fluorescent tags of either eGFP
or DsRed-Express (Table 1) were used to study promoter activa-
tion under anoxic conditions with 400µM KNO3 supplemented
LB as described above.
GFP and DsRed require O2 for chromophore maturation
(Craggs, 2009; Strack et al., 2010). Consequently, 1600 ng ml−1
chloramphenicol (Sigma-Aldrich) was added to the cultures to
prevent new protein synthesis (Toyofuku et al., 2013) with shak-
ing for 1 h at 37◦C in atmospheric air prior to measurement
to allow the chromophore to develop—termed oxic fluorescence
recovery (OFR) (Zhang et al., 2005). The signal was detected
by flow cytometry as described below. The fluorescence values
obtained were corrected for background fluorescence seen in the
control strains with eGFP and dsredexpress unconjugated to a
promoter.
FLOW CYTOMETRY
Detection of reporter strain fluorescence was performed using a
FACSCanto flowcytometer (BD Biosciences, San Jose, CA, USA)
with a 488 nm argon laser. eGFP was detected in FL-1 with a
502 nm long pass filter and a 530/30 nm band pass emission
filter. DsRed-Express fluorescence was collected in FL-2 with a
556 nm long pass filter and 585/42 nm band pass emission fil-
ter. To maximize resolution, samples were analyzed at low flow
rate corresponding to 10µl min−1. At least 10,000 events were
recorded for each sample. Cytometer Setup and Tracking Beads
(BD Biosciences) were used for instrument calibration, and flow
data were processed and analyzed by Diva (BD Biosciences).
DENITRIFICATION GENE TRANSCRIPT EXPRESSION—RNA
EXTRACTION AND REVERSE TRANSCRIPTION
PAO1 was grown in triplicate for 3 h under anoxia with either
unsupplemented LB or LB with 400µM KNO3. The 3 h time
point was chosen as it represented the approximate peak of
promoter activity, as seen in the reporter strains. After 3 h, the cul-
tures were mixed with 2 volumes of RNAlater (Ambion, Austin,
TX, USA) within the anoxic bench for transcript stabilization
and kept at 4◦C overnight before freezing at −80◦C. The cul-
tures were subsequently thawed on ice, centrifuged to harvest the
cells and lysed with 100µl of 1mg ml−1 lysozyme (Affymetrix,
Cleveland, OH, USA) at room temperature for 13min. Total RNA
was extracted with RNeasyMini Kits (QiagenDanmark, Limburg,
NL) and contaminating chromosomal DNA was removed by
treatment with RQ1 RNase-free DNase (Promega, Madison, WI,
USA). RNA quality was detected in a NanoDrop spectropho-
tometer (Thermo Scientific). cDNA was synthesized from 250 to
500 ng of RNA (depending on the concentration extracted) and
High Capacity RNA-to-cDNA Master Mix (Applied Biosystems,
Foster City, CA, US) with a final reaction volume of 20µl in a
2720 Thermal Cycler (Applied Biosystems). The conditions con-
sisted of 5min at 25◦C, 30min at 42◦C, 5min at 85◦C and
subsequent holding at 4◦C. cDNA was frozen at −20◦C. Negative
controls contained template with the Master Mix replaced with
water. cDNA was diluted 1:100 for qPCR.
PRIMER DESIGN
Primers for the denitrification genes narK1, nirS, norC, nosR and
the reference gene rpoD were designed using Integrated DNA
Technologies Primer Quest software (http://www.idtdna.com)
using sequences from the PAO1 Genome Sequence, Pseudomonas
Genome Database (Winsor et al., 2011) (Table 2).
QUANTITATIVE PCR
Each PCR mix had a final volume of 20µl containing 10µl SYBR
Green qPCR Master Mix 2x (Applied Biosystems) 2µl cDNA,
2µl of 2 pmol µl−1 forward and reverse primers and 4µl water.
Quantitative real-time PCR was performed with a StepOnePlus,
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Real-Time PCR system (Applied Biosystems) with initial denatu-
ration at 95◦C for 10min followed by 40 cycles of 95◦C for 15 s,
60◦C for 30 s and 72◦C for 30 s.
Data were normalized to the expression of rpoD, a housekeep-
ing gene encoding the primary sigma factor for RNA polymerase
found to be constitutively expressed in P. aeruginosa (Savli et al.,
2003). To control for variations between runs, the housekeeping
and target genes for each of the three samples were amplified
in one 96-well plate. Expression of the target genes in the cul-
tures with 400µM KNO3 was compared to the unsupplemented
cultures and the difference expressed as n-fold change.
NO−3 AND NO
−
2 QUANTIFICATION
For measuring NO−3 and NO
−
2 concentration in the culture
media, the supernatant was harvested and sterile filtrated through
a syringe filter (TRP, Trasadingen, SUI) (pore size 0.22µm)
and frozen at −20◦C for later measurement. NO−3 and NO−2
were detected in 96-well microtiter plates using a modified
Griess nitrite/nitrate colorimetric assay (Cayman Chemicals, Ann
Arbor, MI, USA) according to manufacturer’s instructions and
as previously described (Kolpen et al., 2014a). Briefly, NO−2
concentration was estimated by incubating with the Griess
Reagent, converting NO−2 into a purple azo-compound detected
by absorbance at 540 nm in a Multiskan EX plate reader (Thermo
Scientific). For NO−3 concentration, NO
−
3 was first converted to
NO−2 by incubation with NO
−
3 reductase and subsequent addi-
tion of the Griess reagent to detect total NO−3 plus NO
−
2 . The
NO−3 concentration was calculated as the difference between the
total NO−2 and NO
−
3 concentration and the NO
−
2 concentration.
The detection limit of the assay was ∼2µM for NO−2 and ∼5µM
for NO−3 .
MICROSENSOR MEASUREMENTS OF N2O
Additionally, reductase activity was elucidated by measuring con-
sumption of NO−3 and production of NO
−
2 as well as mea-
surements of N2O gas accumulation in a nosZ mutant strain
incapable of the final reduction step in denitrification of N2O to
N2. Each small glass vial (Schuett Biotec, Göttingen, DE) contain-
ing anoxic planktonic cultures of either PAO1 WT or the nosZ
mutant were placed in a 37◦C heated rack and kept sealed prior to
individual measurements, upon which they were shaken and the
lid removed. Immediately after, N2O was detected in the media
using an amperometric N2O microsensor (Andersen et al., 2001)
with a tip diameter of 25µm (Unisense A/S, Aarhus, DK) as
previously described (Kolpen et al., 2014a). Each measurement
consisted of a 5 s wait period followed by 5 s measurements taken
at 7, 1mm intervals with data acquisition and sensor positioning
controlled by the Sensortrace Pro 2.0 (Unisense A/S) dedicated
software. Mean experimental N2O concentration was calculated
from triplicates of three individual experiments. The final mean
was corrected for the background signal detected in pure LB.
STATISTICAL ANALYSIS
Data was analyzed for statistical significance with Prism
4 software (GraphPad Software, Inc., La Jolla, CA, USA).
Unless otherwise mentioned, parametric data was analyzed by
One-Way ANOVA with Dunnett’s multiple comparison test
and non-parametric by Friedman’s test with Dunn’s multiple
comparison. P < 0.05 was considered significant.
RESULTS
DENITRIFICATION HAS A SIGNIFICANT ROLE IN ANOXIC GROWTH OF
PAO1 AND CLINICAL ISOLATES AT PHYSIOLOGICAL LEVELS OF NO−3
The specific growth rates of P. aeruginosa grown for 20 h in anoxic
LB supplemented with physiologically relevant concentrations of
NO−3 (0–1mM of NO
−
3 ) were calculated. PAO1 (Figure 2A) and
12 clinical isolates (5 mucoid and 7 non-mucoid) (Figure 2B)
displayed a significant increase in specific growth rate as com-
pared to the unsupplemented control at ≥150µM NO−3 (p =
0.0138) and ≥100µM (p = 0.0132) NO−3 , respectively. Despite
the considerable variation between the growth rates of the clinical
isolates, there was no significant correlation with the duration of
infection as well as no significant difference between the growth
rates of the mucoid and non-mucoid clinical isolates.
FIGURE 2 | Specific growth rates (µ) of P. aeruginosa in anoxic LB
supplemented with NO−3 . (A) PAO1, mean ± s.e.m. of triplicate
experiments, (B) clinical isolates, N = 12, 7 non-mucoid strains
indicated by diamonds and 5 mucoid strains indicated by circles.
Colors indicate the 7 patients isolated from ∗p ≤ 0.05 significant
change from 0µM.
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FIGURE 3 | (A) Specific growth rates (µ) of P. aeruginosa (WT and
nirS-N PAO1) grown in anoxic LB supplemented with NO−3 .
Mean ± s.e.m. of triplicate experiments, ∗p ≤ 0.05 Blue and red
∗ indicate significant increase in µ from 0µM calculated by
One-Way ANOVA. Black ∗ indicate significant difference (p = 0.0316)
between conditions (≥400µM) as calculated by Two-Way ANOVA.
(B) NO−3 and (C) NO
−
2 content of anoxic sterile filtered growth
media after 20 h.
The suitability of the assay was demonstrated in a pilot study
with anoxic cultures of PAO1 supplemented with 100mM NO−3 ,
where our measured growth rate of 0.7 divisions h−1 and final
OD600 of 1.0 (data not shown) corresponded well with previ-
ously reported growth rates of P. aeruginosa (Alvarez-Ortega and
Harwood, 2007; Lee et al., 2012; Fang et al., 2013).
To discern the portion of growth attributable to denitrifica-
tion, we compared the specific growth rates in anoxic cultures
supplemented with NO−3 of the WT to a nirS-N mutant, which
is able to reduce NO−3 to NO
−
2 , but whith a blocked first step of
strict denitrification due to the inability to reduce NO−2 to NO,
under the same growth conditions were estimated (Figure 3A).
NO−3 supports modest growth of the nirS-N mutant with
increasing NO−3 supplementation in accordance with Nar’s con-
tribution to proton motive force generation (Chen and Strous,
2013), but with a significant reduction in growth as compared
to the WT at NO−3 ≥400µM (p = 0.0316). One mM NO−3 was
required to initiate a significant increase in growth rate from the
unsupplemented control in the nirS-N mutant (p = 0.0021).
The consumption of NO−3 and the accumulation of NO
−
2 in
the sterile filtered growth media of the nirS-N mutant at 20 h
confirmed that the ability to reduce NO−3 to NO
−
2 was present in
the nirS-N mutant, but that the mutant failed to further reduce
NO−2 as opposed to the total consumption of NO
−
2 by the WT.
Furthemore, we demonstrated very low concentrations of NO−3
and NO−2 pre-inoculation in LB and that the concentration of
NO−2 was not affected by NO
−
3 (Figures 3B,C).
DYNAMIC INCREASE IN DENITRIFICATION REDUCTASE PROMOTER
ACTIVATION AT 400µMNO−3
The reporter strains were grown under anoxia for 20 h sup-
plemented with 400µM NO−3 and the fluorescence measured
post chloramphenicol addition with OFR by flow cytometry
(Figure 4). The activity of all four promoters was significantly
increased during supplementation with 400µM NO3, but the
time course varied. The Nar activity showed a small peak at 2 h
(p < 0.0001) in comparison to Nor, which showed a stronger
peak at 2–3 h (p < 0.0001). Nir and Nos first showed significant
upregulated promoter activity after 1 h and continued to be so
over 20 h (p < 0.0001 and 0.0273). In all reductases other than
the Nos, there were also periods of significant upregulation in
the unsupplemented control, but for shorter periods of time and
with lower peaks. The transcripts of the denitrification reduc-
tase genes in PAO1 grown under anoxia with 400µMNO−3 hours
showed significant upregulation of nirS, norC and nosR after 3 h
(p-values = 0.014, 0.014, and 0.04) (Figure 5).
We noted that anoxic conditions alone were apparently suffi-
cient to trigger upregulation of some denitrification reductases
as previously observed in other planktonic and biofilm studies
(Härtig and Zumft, 1999; Hentzer et al., 2005; Schreiber et al.,
2007) and that LB is a rich medium which we found to con-
tain ∼20µM NO−3 . We speculate that this is an explanation
for the observed upregulation in our unsupplemented controls.
However, the focus of the present study is on the differences due
to the additional physiological levels of NO−3 supplementation.
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FIGURE 4 | Fluorescence of denitrification reporter promoters of
P. aeruginosa PAO1 during anoxic growth with 0 or 400µM NO−3 . (A)
narK1-eGFP, (B) nirS-dsredexpress, (C) norC-eGFP, (D) nosZ-dsredexpress.
Mean ± s.e.m. as measured by flow cytometry from triplicates. eGFP was
detected in FL-1-A, DsRed-Express was detected in FL-2-A. Bars above
represent the period of time of significant increase p ≤ 0.05.
FIGURE 5 | qRT-PCR on denitrification reductase genes of P. aeruginosa
PAO1 under anoxic growth for 3h in LB with 0 or 400µM NO−3 .
Expression was normalized to the housekeeping gene rpoD. Values show
fold change from 0µM with theoretical median of 1. N = 6 with median.
∗p ≤ 0.05, ∗∗p ≤ 0.01.
NO−3 IS RAPIDLY CONSUMEDWITH A SUBSEQUENT TRANSIENT
INCREASE OF NO−2 IN ANOXIC GROWTH MEDIA
Medium from the reporter PAO1 strains showed that 400µM
NO−3 was depleted to below the detection level of the Griess
assay within just 2 h with a transient increase in the product
of its reduction, NO−2 (Figure 6). This rapid depletion com-
bined with the time taken to harvest the supernatant is the likely
FIGURE 6 | Consumption and production of NO−3 and NO
−
2 during
anaerobic growth of P. aeruginosa PAO1. N = 4, mean ± s.e.m. Initial
NO−3 : Open squares 0µM KNO3, closed squares 400µM KNO3.
explanation for the initial time point showing somewhat less than
the expected 400µM NO−3 , as the media pre-inoculation was
tested and confirmed to contain 400µMNO−3 .
N2O IS PRODUCED IN RESPONSE TO NO−3 SUPPLEMENTATION
The nosZ mutant and a WT PAO1 strain were grown with
physiological concentrations of NO−3 under anoxia and the aver-
age N2O accumulation over 20 h detected. With as little as
62.5µM NO−3 , a significant production of N2O was stimu-
lated (p = 0.0125) (Figure 7). The WT produced <10µM of
N2O at all experimental concentrations of NO
−
3 ; confirming
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FIGURE 7 | N2O production by P. aeruginosa PAO1 grown over 20h in
anoxic LB supplemented with NO−3 in triplicate. Mean ± s.e.m.∗p ≤ 0.05 indicating significant increase of N2O production by nosZ.
the defective conversion of N2O to N2 by the nosZ
mutant.
DISCUSSION
P. aeruginosa is able to thrive under anoxic conditions by per-
forming denitrification. Our initial studies performed with clin-
ical isolates and PAO1 under anoxic conditions showed that
physiological concentrations of NO−3 are sufficient to support a
significant increase in growth rate, even in cultures supplemented
with less NO−3 than the 400µM applied by Palmer et al. (2007).
The anoxic growth rates obtained are comparable to those
reported in CF lungs and sputum, except for the very low growth
rates in some of the clinical samples from CF lungs and sputum
(Yang et al., 2008; Kragh et al., 2014). This is likely due to our
planktonic studies representing a slightly faster growth rate as the
shaken cells have equal access to nutrients in the media, whereas
in the biofilm mode of growth in the lungs, internal cells are
assumed to have access to less nutrients, including NO−3 , due to
diffusion limitation and utilization by cells at the periphery of the
biofilm (Bjarnsholt et al., 2009). Additionally, ∼10% of the cells
in clinical samples appear to be in stationary phase (Yang et al.,
2008) whereas the growth rates in our experiments are calculated
from the exponential growth phase. In the lungs, P. aeruginosa is
also under continual attack from the host inflammatory response
and antibiotic stress (Høiby, 2006), which is also likely to reduce
the rate of growth.
Nar is required for anoxic growth at physiological levels of
NO−3 in CF sputum (Palmer et al., 2007) and accordingly NO
−
3
reduction alone is able to generate some growth as seen in
the nirS-N mutant, unable to perform the subsequent NO−2
reduction and therefore blocking denitrification. However, we
demonstrate that the nirS-N mutant requires the highest phys-
iological concentration of 1mM NO−3 , seen only in exacerbated
CF patients following antimicrobial treatment (Grasemann et al.,
1998), to enable a significant increase in growth rate as well as
a significant reduction of growth as compared to the WT. This
indicates a substantial additional contribution of denitrification
to the observed anoxic growth of P. aeruginosa at physiological
levels of NO−3 . Anoxic growth of mutants with defective Nir was
also reduced at concentrations of NO−3 greater than physiologi-
cal levels [10mM (Schreiber et al., 2007) and 100mM (Filiatrault
et al., 2006)].
In addition to supporting anoxic growth, Nir may promote
the persistence of P. aeruginosa in the infected CF lungs as Nir is
required for type III secretion resulting in prolonged survival in
human monocytes (Van Alst et al., 2009) and enhanced virulence
(Filiatrault et al., 2006). This supports the idea that denitrification
is necessary for achieving the observed growth of P. aeruginosa in
the lungs.
The dynamic increase in the promoter activity of all four
denitrification reductases over 20 h and increased expression of
all transcripts but the narK1 at 3 h with 400µM NO
−
3 further
emphasized the engagement of denitrification. The explanation
for the transient peak in Nar expression and lack of upregula-
tion at 3 h became apparent after analysing the growth media for
NO−3 content, showing depletion after just 2 h. Expression of Nar
is controlled in part by the two-component NO−3 -sensing regu-
lator NarX-L (Schreiber et al., 2007; Schobert and Jahn, 2010)
so presumably after NO−3 depletion Nar expression is no longer
induced. The Nor is also proposed to be under NarX-L control
(Schobert and Jahn, 2010), which would explain the decrease in
promoter activity after 2 h.
The Nar product, NO−2 displayed a transient increase in
the growth media which was similarly rapidly depleted by 3 h.
However, the expression of Nir and Nos appeared to be less
tightly regulated by N-oxide concentration as they were still
significantly upregulated at 20 h, and in the case of the Nir,
only a modest increase in expression was stimulated by NO−3
supplementation. The additional O2-sensing Anr regulator and
downstream NO sensing dissimilative nitrate respiration (Dnr)
regulator (Schreiber et al., 2007; Schobert and Jahn, 2010; Trunk
et al., 2010; Arai, 2011)may play amore important role in Nir and
Nos regulation (Schreiber et al., 2007; Schobert and Jahn, 2010)
and hence their expression more responsive to the anoxic condi-
tions and the downstream denitrification product NO resulting
in prolonged increase in expression.
As N-oxides are not exclusively utilized in strict
denitrification—NO−3 reduction is also able to feed into
dissimilatory pathways for ammonia excretion or into assim-
ilatory pathways for incorporation into biomolecules (Zumft,
1997)—we also studied N2O production. The known pathways
for N2O production are denitrification and nitrification via oxi-
dation of hydroxylamine to N2O (Khalila et al., 2004). As of yet,
there is no evidence to suggest that P. aeruginosa performs or pos-
sesses homologs of the enzymes required for nitrification [PAO1
Genome Sequence, Pseudomonas Genome Database (Winsor
et al., 2011)]. Additionally, the process requires O2 (Meyer et al.,
2008) and thus for our anoxic experiments we assumed that all
detected N2O was produced via the denitrification pathway and
therefore acted as a specific marker. In the P. aeruginosa nitrous
oxide reductase mutant nosZ, unableto reduce N2O to N2, we
found a significant accumulation of N2O in the anoxic growth
media with as little NO−3 supplementation as 62.5µM. This find-
ing further supports that P. aeruginosa employs denitrification to
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obtain energy for growth at physiological levels of NO−3 in anoxic
conditions.
Interestingly, one late clinical strain isolated from a patient
chronically infected for 35 years, was unable to grow in anoxic
conditions with NO−3 . This may relate to adaptations of more
flexible nitrate metabolism over time, with denitrification sug-
gested to no longer be essential for growth for some strains at
later phases of infection (Oberhardt et al., 2010; Cramer et al.,
2011). While NO−3 was unable to stimulate anoxic growth of
the late isolate, alternative anoxic growth may occur by argi-
nine fermentation (Vander Wauven et al., 1984) and survival
could be facilitated by pyruvate fermentation (Eschbach et al.,
2004) and phenazine redox cycling (Glasser et al., 2014; Quinn
et al., 2014). Alternatively, the late isolate may have adapted
to favor growth in the alveoles where oxygen is supplied by
inspired air and capillaries surrounding the alveoles (West,
2000).
It has previously been shown that micro-oxic conditions are
able to support growth of P. aeruginosa (Alvarez-Ortega and
Harwood, 2007). Here we substantiate that physiological con-
centrations of NO−3 are also able to support growth by den-
itrification in anoxic conditions, highlighting the flexibility of
P. aeruginosa’s ability to survive in a range of environments in
the CF airways (Worlitzsch et al., 2002; Aanaes et al., 2011;
Kolpen et al., 2014a). Interestingly, physiological concentra-
tions of NO−3 may also enhance growth of P. aeruginosa even
at micro-oxic conditions since a growth advantage of labora-
tory strains carrying a lasR mutation, which is associated with
severe lung damage in infected CF patients (Hoffman et al.,
2009), was obtained with supplementation of only 125µM NO−3
in conditions with limited O2 mass-transfer (Hoffman et al.,
2010).
In conclusion, P. aeruginosa is readily able to adapt to the
physiological levels of NO−3 and lack of O2 in the infected CF
lungs by employing denitrification. The ability of P. aeruginosa
to grow under anoxia has clinical relevance as multiple classes of
antibiotics are known to have reduced efficacy in the absence of
O2 (Walters et al., 2003; Dwyer et al., 2014). Denitrification may
consequently be a major factor in P. aeruginosa’s observed toler-
ance to antibiotic treatment in CF patients (Høiby et al., 2010).
This tolerance may be overcome by directing antibacterial treat-
ment against denitrification as suggested by the downregulation
of narG and narH resulting in increased susceptibility of P. aerugi-
nosa to fosfomycin and tobramycin combination treatment under
anoxic conditions (McCaughey et al., 2013). Denitrification has
also recently been proposed to contribute to the pathogenicity of
bacterial species infecting CF lungs due to its activity in P. aerug-
inosa as well as the highly pathogenic species Achromobacter
xylosoxidans and Burkholderia multivorans in comparison to the
less pathogenic Stenotrophomonas maltophilia which is unable to
perform denitrification (Kolpen et al., 2014c). Accordingly, our
results underline the importance of developing novel treatments
that target P. aeruginosa’s flexible metabolism more broadly, with
the denitrification reductases presenting potential targets, and
that can be administered to reach the varied lung microen-
vironments that P. aeruginosa is able to adapt to and persist
within.
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